Vemurafenib treats a specific type of melanoma, the most serious form of skin cancer, as a targeted therapy medication.
It works by targeting a mutated gene called B R A F, which is found in many melanoma cells.
How Vemurafenib Works:
- B R A F Mutation: In certain types of melanomas,
- the B R A F gene is mutated
- leading to abnormal signaling that promotes cancer cell growth and survival.
- B R A F Inhibition: Vemurafenib binds to and inhibits the mutated B R A F protein, blocking its abnormal signaling.
- Cancer Cell Apoptosis: This inhibition of B R A F signaling can lead to the death of cancer cells.